摘要 |
<p>There are provided compounds of formula (I), wherein R<sup>1</sup>, R<sup>6</sup>, R<sup>8</sup>, Q<sup>2</sup>, Q<sup>3</sup>, Q<sup>3a</sup>, Q<sup>4</sup>, L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer.</p> |